United States Biotechnology & Medical Research

Achieve Life Sciences Inc (ACHV)

Track

The most recent insider trading activity occurred on September 18, 2025, with significant sell transactions by the CEO and CFO. Prior to this, on September 4, 2025, several executives, including the Chief Commercial Officer and President & CMO, also engaged in substantial sell-offs. Earlier buy transactions by executives were noted in March 2025 and March 2024.
Stock chart
Ticker: ACHV Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Oki Mark K
Chief Financial Officer
1 sale — total 146,175 USD
Sale 18 Sep 2025
Value US$2,804,895.96 | Price 60.99 | Shares 63,427
Sale 18 Sep 2025
Value US$35,855.84 | Price 153.66 | Shares 90,401
Sale 4 Sep 2025
Value US$38,973.90 | Price 2.77 | Shares 14,070
Sale 4 Sep 2025
Value US$387,406.66 | Price 2.77 | Shares 139,858
Sale 4 Sep 2025
Value US$76,532.33 | Price 2.77 | Shares 27,629
Sale 4 Sep 2025
Value US$57,765.58 | Price 2.77 | Shares 20,854
Buy 17 Mar 2025
Value US$28,598.00 | Price 2.86 | Shares 10,000
Buy 17 Mar 2025
Value US$28,887.00 | Price 2.89 | Shares 10,000
Buy 4 Mar 2024
Value US$45,850.00 | Price 4.59 | Shares 10,000
Buy 4 Mar 2024
Value US$45,850.00 | Price 4.59 | Shares 10,000
Buy 30 May 2023
Value US$27,500.00 | Price 5.50 | Shares 5,000
Buy 18 Nov 2022
Value US$0.00 | Price 0.00 | Shares 22,000
Buy 27 May 2021
Value US$42,000.00 | Price 7.00 | Shares 6,000
Sale 11 Jun 2019
Value US$0.00 | Price 0.00 | Shares 0
Sale 11 Jun 2019
Value US$128,500.00 | Price 2.57 | Shares 50,000
Sale 11 Jun 2019
Value US$0.00 | Price 0.00 | Shares 0
Sale 11 Jun 2019
Value US$7,590.00 | Price 2.53 | Shares 3,000
Sale 11 Jun 2019
Value US$0.00 | Price 0.00 | Shares 0
Sale 11 Jun 2019
Value US$170,806.58 | Price 2.66 | Shares 64,213
Sale 11 Jun 2019
Value US$0.00 | Price 0.00 | Shares 0
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-09-22 2025-09-18 S Sale
1.6
Oki Mark K

Chief Financial Officer

Officer
63,427 -0.7%
60.99
US$2,804,896 		63,427 -0.7% 60.99 US$2,804,896
2025-09-22 2025-09-18 S Sale
1.2
Stewart Richard Alistair

Chief Executive Officer

Executive Director
90,401 -22.4%
153.66
US$35,856 		90,401 -22.4% 153.66 US$35,856
2025-09-08 2025-09-04 S Sale
0.5
Wan Jerry

Principal Accounting Officer

Officer
36,522 -26.5%
420.39
US$1,591,240 		36,522 -26.5% 420.39 US$1,591,240
2025-09-08 2025-09-04 S Sale
0.5
KING THOMAS BRAXTON
Non-Executive Director
139,858 -30.7%
2.77
US$387,407 		139,858 -30.7% 2.77 US$387,407
2025-09-08 2025-09-04 S Sale
0.5
JACOBS CINDY

President & CMO

Officer
27,629 -19.3%
2.77
US$76,532 		27,629 -19.3% 2.77 US$76,532
2025-09-08 2025-09-04 S Sale
0.5
Xinos Jaime

Chief Commercial Officer

Officer
20,854 -21.9%
2.77
US$57,766 		20,854 -21.9% 2.77 US$57,766
2025-03-19 2025-03-17 B Purchase
1.2
Stewart Richard Alistair

Chieve Executive Officer

Executive Director
10,000 +19.7%
2.86
US$28,598 		10,000 +19.7% 2.86 US$28,598
2025-03-19 2025-03-17 B Purchase
1.6
Oki Mark K

Chief Financial Officer

Officer
10,000 +inf%
2.89
US$28,887 		10,000 +inf% 2.89 US$28,887
2024-03-06 2024-03-04 B Purchase
2.7
Bencich John

CEO

Executive Director
10,000 +15.0%
4.59
US$45,850 		10,000 +15.0% 4.59 US$45,850
2024-03-06 2024-03-04 B Purchase
1.2
Stewart Richard Alistair

Executive Chairman

Executive Director
10,000 +35.1%
4.59
US$45,850 		10,000 +35.1% 4.59 US$45,850
2023-06-01 2023-05-30 B Purchase
2.7
Bencich John

CEO

Executive Director
5,000 +8.1%
5.50
US$27,500 		5,000 +8.1% 5.50 US$27,500
2022-11-21 2022-11-18 B Purchase
2.7
Bencich John

CEO

Executive Director
22,000
0.00
US$0 		22,000 0.00 US$0
2021-05-27 2021-05-27 B Purchase
2.7
Bencich John

CEO

Executive Director
6,000 +4255.3%
7.00
US$42,000 		6,000 +4255.3% 7.00 US$42,000
2019-06-13 2019-06-11 S Sale
2.5
ARMISTICE CAPITAL, LLC
Large shareholder
0
0.00
US$0 		0 0.00 US$0
2019-06-13 2019-06-11 S Sale
2.5
ARMISTICE CAPITAL, LLC
Large shareholder
50,000 -5.6%
2.57
US$128,500 		50,000 -5.6% 2.57 US$128,500
2019-06-13 2019-06-11 S Sale
2.5
ARMISTICE CAPITAL, LLC
Large shareholder
0
0.00
US$0 		0 0.00 US$0
2019-06-13 2019-06-11 S Sale
2.5
ARMISTICE CAPITAL, LLC
Large shareholder
3,000 -0.3%
2.53
US$7,590 		3,000 -0.3% 2.53 US$7,590
2019-06-13 2019-06-11 S Sale
2.5
ARMISTICE CAPITAL, LLC
Large shareholder
0
0.00
US$0 		0 0.00 US$0
2019-06-13 2019-06-11 S Sale
2.5
ARMISTICE CAPITAL, LLC
Large shareholder
64,213 -6.7%
2.66
US$170,807 		64,213 -6.7% 2.66 US$170,807
2019-06-13 2019-06-11 S Sale
2.5
ARMISTICE CAPITAL, LLC
Large shareholder
0
0.00
US$0 		0 0.00 US$0
Explore more

More insider trading research around Achieve Life Sciences Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America